The Ebola-Tx trial (i.e. Emergency evaluation of convalescent plasma for Ebola Virus Disease in Guinea) evaluated the safety and efficacy of CP as potential treatment for EVD [9]. Here, CP is linked to Ebola hemorrhagic fever.